Hair exosome treatment is a term used for exosome-based approaches being studied for hair loss. Exosomes are small vesicles released by cells that participate in communication between cells. Although research is attracting interest, clinical evidence on effectiveness, safety and standardised hair-loss protocols remains limited.
Genetic factors, hormonal changes, nutritional deficiencies and scalp conditions can produce similar concerns. The starting point is an assessment of the hair and scalp. Tests or specialist review may be suggested where appropriate. A product marketed under the exosome label does not replace identifying the cause or considering established treatment options.
Products marketed as exosomes can differ in source, composition and manufacturing. Being sold for cosmetic use does not establish that a product is suitable for injection. Before considering an application, a doctor should assess intended use, relevant authorisations, delivery route and available evidence. A standard dose or session schedule should not be assumed.
New hair growth, complete control of shedding or lasting increases in density cannot be guaranteed. Baseline assessment and a follow-up method help evaluate any change. Where an application is considered, product-specific and procedure-specific risks should be explained. Uncertainty, alternatives and follow-up needs are part of an informed decision.
No. A transplant moves hair follicles; exosome-based approaches do not involve that surgical process.
No. Current evidence does not support such a guarantee.
No. PRP is prepared from your blood. Exosome products may have different sources and preparation methods.
No. The delivery route must be appropriate to the product and its relevant authorisations.
Suitability and the product must be assessed first. There is no universal session count or price.
Contact Clinic Galata to discuss hair-loss assessment and the options available for your needs.
